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Abstract. A new synthetic approach to hexahydroisoindol-
4-ones is reported, based on the formal [3+2] cyclization 
reaction between N-arylsulfonylimines and cyclic 
conjugated dienes, under phosphine catalysis. Key 
substrates are 3-vinylcyclohex-2-enones with electron-
withdrawing substituents (ester, amido, cyano, phosphoryl 
and keto groups) on the exocyclic double bond, which 
afford the three atom synthons for the construction of the 
 
pyrroline ring. Total syn stereoselectivity is observed in 
these annulations. The scope of the reaction has been 
demonstrated and mechanistic issues are considered, 
based on deuteration experiments and DFT calculations.  
Keywords: phosphine organocatalysis; conjugated dienes; 
imines; hexahydroisoindolones;[3+2] annulations  
 
1 Introduction 
Isoindoline units are commonly found in 
biologically relevant compounds and drug candidates 
displaying a remarkable variety of activities.[1] The 
related perhydroisoindol-4-ones have also found 
applications as core scaffolds or synthetic 
intermediates in medicinal chemistry.[2] Common 
synthetic strategies toward saturated fused bicyclic 
amines of this class mainly involve the 1,3-dipolar 
cycloaddition of azomethine ylides on suitable cyclic 
olefins[3] or Diels-Alder type reactions on 
maleimide.[4,5] 
 
 
 
Scheme 1 Synthetic approaches to perhydroisoindol-4-one 
scaffolds. 
 
A new, alternative and practical synthesis of 
hexahydro-4H-isoindol-4-one derivatives is reported 
hereafter, based on phosphine catalyzed [3+2] 
cyclizations[6] which involve imines and dienes as the 
two atom and three atom components respectively. 
The method has been unexpectedly brought to light 
while expanding the scope of the recently disclosed 
reaction between electron-poor conjugated dienes  
and imines, under phosphine catalysis, shown in 
Scheme 2.[7] In this reaction, starting from acyclic 
conjugated dienes properly activated by electron-
withdrawing groups on both ends, 3-pyrrolines were 
produced.[8] The cyclization took place selectively on 
the double bond substituted by the ester function, 
following to formal activation of this bond by the 
nucleophilic phosphine. 
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Scheme 2. Synthesis of  pyrrolines from conjugated dienes 
and imines under phosphine catalysis.[7]  
As a logical extension of this previous work, the 
same strategy has been applied then to conjugated 
dienes where one of the double bonds is embedded in 
a cyclic moiety. These experiments have allowed an 
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efficient access to the hexahydroisoindol-4-one 
scaffolds 3 to be implemented, as shown hereafter.  
2 Results and Discussion 
 
With the purpose of expanding the scope of the 
phosphine promoted annulations reactions between 
imines and conjugated dienes shown in Scheme 2,[7] 
we have considered the known 3-(2-methoxy-
carbonylvinyl)-2-cyclo-hexenone 1a[9] as a model 
substrate for initial studies. Diene 1a has been reacted 
with N-tosyl-benzaldimine in the presence of trivalent 
phosphines as nucleophilic catalysts (Scheme 3). A 
clean reaction took place indeed, leading to the 
bicyclic pyrroline 3a, whose formation has been 
optimized by a rapid screening of catalysts (PBu3, 
PMe3, PMe2Ph, PMePh2, PPh3, P(i-Bu)3) and reaction 
conditions. The optimized conditions include the use 
of PBu3 as the catalyst, a 2:1 imine:diene ratio, polar 
solvents (methyl ethyl ketone or t-BuOH) and a 
reaction temperature of 80°C. In MEK, with a 10 
mol% amount of the phosphorus catalyst, total 
conversion could be attained after 18h.  
 
 
Scheme 3. Phosphine promoted annulation between the 
cyclic diene 1a and imine 2a. 
The molecular structure of 3a has been assigned at 
first by NMR and unambiguously established then by 
X-ray crystallography on the corresponding 
hydrazone 3a’ (Figure 1).[10] NMR and structural data 
indicate that the reaction affords exclusively the syn 
isomer of the bicyclic fused pyrroline, with total 
chemo- and stereoselectivity.  
 
 
Figure 1. X-ray crystal structure of hydrazone 3a’. 
The outcome of this cyclization reaction highlights a 
stricking chemodivergent behaviour of the cyclic 
diene 1a with respect to the acyclic analogue I, as far 
as cyclization takes place on the enone function of 1a 
while it was shown to take place on the enoate 
function of I. This result rises some mechanistic 
concerns which will be discussed briefly in final 
section of this paper.  
 
Since a variety of hexahydroisoindol-4-ones 
might be easily available from simple starting 
materials following the synthetic strategy typified in 
Scheme 1, we next examined the scope of this 
catalytic process. Representative results are depicted 
in Table 1. The cyclization reaction can be performed 
with tosylimines bearing substituted aryls, heteroaryls 
(entry 3) and alkyl groups (entry 7). It also tolerates 
p-chloro- and p-nitro phenylsulfonyl activating 
groups on the nitrogen atom (entries 8, 9), while N-
DPP imines failed to react. Most reactions take place 
at 80°C with a 10 mol% amount of PBu3, but in some 
cases it may be advantageous to increase the catalyst 
amount or the temperature in order to increase the 
conversion rates. Both methyl ethyl ketone (MEK) 
and t-BuOH are suitable solvents. According to NMR 
analyses, the crude final mixtures contain 3 and, 
possibly, some residual starting material, with only 
minor amounts of side products. 
Table 1. Phosphine promoted synthesis of the hexahydro-
isoindol-4-ones 3: variations of the imine partner. 
 
 
 Imine R R1 PBu3 % Prod. 
Yield 
%[a] 
1 2b 4-Cl-C6H4 Ts 10 3b 93 
2 2c 4-CF3-C6H4 Ts 30 3c 78 
3 2d 2-thienyl Ts 10 3d 76 
4 2e 4-MeO-C6H4 Ts 30 3e 82[b] 
5 2f 1-naphthyl Ts 10 3f 83 
6 2g p-NO2-C6H4 Ts 30 3g 47[c] 
7 2h i-Pr Ts 30 3h 71[d] 
8 2i Ph 4-Cl-PhSO2 10 3i 82 
9 2j Ph 4-NO2-PhSO2 10 3j 44 
 [a] Conditions: reactions have been performed at a 0.3 
mmol scale, under Ar, in degassed MEK (1 mL, entries 1-5 
and 8) or t-BuOH (1 mL, entries 6,7,9); diene:imine ratio = 
1:1.5, unless otherwise stated. [b] Reaction temperature: 
100°C. [c] diene:imine ratio = 1:2.  [d] Diene:imine ratio = 
1:3 
 
The fused bicyclic pyrrolines 3b-j were obtained as 
single isomers which have been assigned as the syn 
isomers by analogy to 3a, based on their typical 1H 
NMR pattern. The two NCH units display signals at δ 
= 5.6 (d, J ~ 1.2 Hz, NCHAr) and 5.0 ppm, while the 
chemical shifts of the CH2-CO2Me units are at about 
 3 
3 ppm (AB system with 2JH-H~16 Hz, 3JH-H ~4 and ~8 
Hz).  
 
Further efforts have been directed then toward 
modulation of the withdrawing group of the diene 
moiety (Scheme 4). Dienes 5a-e bearing keto, amido, 
cyano and diethylphosphoryl functions on the 
external double bond, have been prepared by Heck 
reaction from either 3-tosyloxy- or 3-bromo-2-
cyclohexenones and suitably functionalized olefins. 
They have been reacted then with N-
tosylbenzaldimine in the presence of PBu3 in MEK. 
 
 
Scheme 4. Synthesis of hexahydroisoindol-4-ones with 
various functional groups tethered to the 1-position.  
Compared to 1a, the new dienic substrates 5 
displayed lower reactivity, nevertheless the desired 
hexahydroisoindol-4-ones 6 could be obtained in 
moderate to good yields for reactions carried out at 
100°C, with about 30 mol% catalyst.[11] In these 
reactions also, the final products were isolated as 
single isomers.  
 
In additional experiments, variation of the ring 
size of the dienic substrate has been attempted by 
considering the five-member cyclic diene 7 as a 
possible reaction partner. Diene 7 has been prepared 
by Heck reaction between methyl acrylate and 3-
iodocyclopent-2-enone,[12] with Pd(OAc)2/ 
Ph2P(CH2)3PPh2 as the catalyst. In the usual 
conditions, the reaction of 7 with N-
tosylbenzaldimine failed to give the expected 
pyrroline displaying a bicyclo-[3.3.0] scaffold. It 
produced however the aza-Morita-Baylis-Hillman 
adduct 8 in 70% yield.  
 
 
Scheme 5. Aza-Morita-Baylis-Hillman type reaction of 
vinylcyclopentenone 7 and N-tosylbenzaldimine. 
 
The aza-MBH reaction takes place selectively on the 
enone function, despite the fact that this will involve 
formal activation of a trisubstituted double bond by 
the phosphorus nucleophile. As far as we know, this 
is an unprecedented example of phosphine promoted 
aza-MBH reaction on a β-substituted cyclic enone. 
 
In summary, results in Scheme 5 show that, in 
the case of cyclopentenone derivatives, the annulation 
reaction is no longer competitive with the direct 
elimination of the phosphine leading to the classical 
aza-MBH adduct. Therefore, the application field of 
our method is restricted so far to the synthesis of the 
[4.3.0]-bicyclic moiety of isoindolinones. 
 
Finally, in order to expand the synthetic utility of 
the method, we have checked the feasibility of 
nitrogen deprotection in the final bicyclic product. To 
this end, we have considered the N-nosyl protected 
tetrahydroisoindolone 3j, since mild deprotection 
protocols are known for the nosyl group. The nosyl 
group could be removed actually by reaction of 3j 
with thiophenol in the presence of sodium carbonate 
(Scheme 6).[13]  
 
 
Scheme 6. Removal of the nosyl protecting group from 
isoindoline 3j. 
The final secondary amine has been isolated from the 
crude reaction mixture, in pure form and good yield 
(66%), by extraction in acid solution. NMR data 
show that the bicyclic pyrroline ring is retained 
during the deprotection procedure. 
 
 
Mechanistic considerations 
On a mechanistic point of view, the most 
straightforward pathway for building the 
tetrahydroisoindolines 3 (or 6) would involve 
addition of the phosphorus nucleophile to the 
intracyclic double bond of 1 or 5 (path a in Scheme 
7), followed by nucleophilic addition of A to the 
imine. Intermediate A1 should undergo then an 
intramolecular Michael type addition leading to A2. 
A formal [1,4]-proton shift will then convert A2 into 
A3 and create a negative charge β-to the phosphorus 
centre. The phosphine elimination step achieves the 
cyclization process. This mechanism implies the 
preferential activation of the internal, trisubstituted 
double bond of the starting diene, vs. activation of the 
disubstituted enoate function via intermediate B 
(Scheme 7b). This is rather unexpected, especially 
when considering that the related phosphine 
promoted aza-Morita-Baylis-Hillman reactions 
seldom apply to β-substituted Michael acceptors.[14,15]  
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Scheme 7. (a) A straightforward mechanism for the 
annulation reaction. (b) Alternative zwitterionic 
intermediates generated by phosphine addition to the 
conjugated dienes.  
Therefore, in order to get additional information on 
possible reaction intermediates, the cyclization 
between 5a and 2a has been performed in the 
presence of excess D2O, as shown in Scheme 8. 
Since H-shifts are known to be mediated by traces of 
water,[16] deuterium is expected to be incorporated on 
all positions involved in H-shift processes.  
 
 
 
Scheme 8. Cyclization reaction in the presence of D2O 
The sample of 6a isolated from this experiment 
contains a significant amount of deuterium (70%) at 
the methylene carbon α to the COMe function. This 
was fully anticipated, due to the postulated formation 
of intermediate A2. However, deuterium has been 
partially incorporated also at the C1 carbon of 6a 
(30%) while the C3 moiety contains only protons. 
The mechanism shown in Scheme 7a does not 
account, by itself, for the observed deuterium 
distribution, since it does not involve H-exchanges at 
the C1 carbon. 
Therefore, less straightforward mechanisms can’t be 
excluded so far, which might involve initial addition 
of the phosphorus catalyst to other sites of the dienic 
moiety.  
 
According to Hückel and quantum chemical 
calculations, the LUMO orbital of conjugated dienes 
such as 1a or 5a is distributed along the dienic unit, 
with roughly identical coefficients on the four atoms 
(Figure 2).  
 
 
 
 
Figure 2. LUMO coefficients for the dienic carbon atoms 
at the HF and Hückel (in bracket) levels (top) and 
qualitative view of the LUMO at the DFT level (bottom) 
for A) 1a and B) 5a.  
Consequently, the zwitterionic species B, C and D 
(Scheme 7b) might also be formed by addition of the 
nucleophilic phosphine to the α, γ and δ positions of 
the dienic ketone. They might enter a catalytic cycle 
or, alternatively, their reversible formation might 
induce H/D exchange reactions accounting for the 
observed D-distribution in the final product 6a 
(Scheme 8).  
 
The reversible addition of tributylphosphine to the 
diene has been evidenced by the H/D exchange 
experiment shown in Scheme 9.  
 
 
Scheme 9. PBu3-promoted, H/D exchange reactions.  
When 5a was stirred at r.t. in the presence of PBu3 
and D2O, deuterium has been incorporated in 
comparable amounts on the α, γ and δ carbons of the 
starting dienic unit.  
Thus, experimental data and calculations support the 
hypothesis of an initial, reversible addition of the 
phosphorus nucleophile to various positions of the 
dienic substrate generating different zwitterionic 
adducts. The reaction outcome will be determined 
then at a later step of the catalytic cycle.  
Additional studies are required to enlighten the 
precise mechanism of these cyclization  reactions. 
 
3 Conclusion 
 
This work demonstrates that the phosphine-
mediated organocatalytic annulations between 3-
vinylcyclohexenones and N-arylsulfonylimines 
produce hexahydroisoindol-4-ones with various 
functional groups connected to the C1-carbon by a 
CH2 spacer. This represents a new, easy and 
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stereoselective access to isoindoline derivatives with 
an unprecedented substitution scheme. Insights into 
the reaction mechanism have been obtained from 
deuteration experiments and DFT calculations which 
demonstrate the reversible addition of the phosphorus 
catalyst to the dienic unit.  
The method proved unsuitable for the direct 
synthesis of the analogous 2-aza-bicyclo[3.3.0] units 
from cyclopentenone derivatives. Cyclic substrates 
with different ring sizes are now considered in 
ongoing studies.  
Experimental Section 
Synthesis of the conjugated dienes 1, 5 and 7 via Heck 
reactions. (a) Dienes 1a and 5a,c,e have been prepared 
from tosylate 4a according to the reported method.[9] 
Representative procedure: A mixture of tosylate 4a (4.0 g, 
15 mmol), a suitable olefin H2C=CHZ (22 mmol), Et3N (3.3 mL, 24 mmol), Pd(OAc)2 (50.6 mg, 0.22 mmol) and 
PPh3 (59 mg, 0.22 mmol) in degazed N,N-
dimethylacetamide (11 mL) / DMF (4.5 mL) was heated at 
105°C under argon for 24h. The reaction mixture was 
routinely monitored by 1H NMR. If needed, additional 
amounts of Pd(OAc)2/PPh3 were added to achieve total 
conversion of the starting tosylate.After aqueous workup 
with HCl 0.5N, the organic layer was washed with 
NaHCO3 and water and evaporated to dryness. The final 
product was purified by column chromatography on silica 
gel.  
(E)-N,N-dimethyl-3-(3-oxocyclohex-1-enyl)acrylamide 
(5c) has been obtained in 59% yield (0.85 g, 4.4 mmol) 
from tosylate 4a (2.0 g, 7.5 mmol) and N,N-dimethyl 
acrylamide (1.1 g, 11 mmol) (Method a). The final product 
has been purified by column chromatography with ethyl 
acetate (Rf = 0.2) as the eluent.  1H NMR (CDCl3): δ 7.27 (d, J = 15.6 Hz, 1H), 6.69 (d, J = 15.6 Hz, 1H), 6.11 (s, 1H), 
3.10 (s, 3H), 3.01 (s, 3H), 2.50-2.39 (m, 4H), 2.09-2.00 (m, 
2H);13C NMR (CDCl3): δ 199.8 (CO), 165.6 (CO-N), 154.5 (C), 141.9, 131.4, 123.5, 37.6 (Me), 37.4 (Me), 35.9, 25.1, 
22.1 ppm. 
 
(E)-diethyl 2-(3-oxocyclohex-1-enyl)vinylphosphonate 
(5e) has been obtained in 73% yield (1.3 g, 5.0 mmol) from 
tosylate 4a (2.0 g, 7.5 mmol) and diethyl vinylphosphonate 
(1.1 g, 6.8 mmol). 1H NMR (CDCl3): δ 7.12 (dd, JH-P = 21.8 
Hz, J = 17.4 Hz, 1H), 6.11 (t, JH-P ~JH-H = 17.7 Hz, 1H), 
6.06 (s, 1H), 4.06 (m, 4H), 2.40 (m, 4H, OCH2), 2.03 (m, 
2H), 1.29 (t, J = 7.1 Hz, 6H, Me) ppm. 13C NMR (CDCl3): δ 199.7 (CO) 153.8 (d, J = 23.5 Hz), 147.9 (d, J = 6.6 Hz), 
132.0 (=CH), 121.2 (d, J = 189 Hz, PCH), 62.1 (d, J = 6.0 
Hz, OCH2), 37.6, 24.5, 21.9, 16.3 (d, J = 6.1 Hz, Me); 31P 
NMR (CDCl3): δ 17 ppm. 
 
(b) Dienes 5b and 5d have been prepared by Heck 
reactions between 3-bromocyclohex-2-enone 4b and the 
corresponding olefins, following the same procedure. The 
reactions are completed after heating for 2h at 85°C.  
(E)-3-(3-oxo-3-phenylprop-1-enyl)cyclohex-2-enone (5b) 
has been obtained in 71% yield (0.92 g) from the bromide 
4b (1.0 g, 5.7 mmol) and phenyl vinyl ketone (1.0 g, 7.5 
mmol). 1H NMR (CDCl3): δ 7.90 (d, J = 7.0 Hz, 2H), 7.53 (m, 1H), 7.4 (m, 2H), 7.39 (d, J = 17 Hz, 1H), 7.21 (d, J = 
17 Hz, 1H), 6.20 (s, 1H), 2.54 (m, 2H), 2.43 (m, 2H), 2.06 
(m, 2H) ppm. 
 
(E)-3-(3-oxocyclohex-1-enyl)acrylonitrile (5d) has been 
obtained in 44% yield (0.37 g) from bromide 4b (1.0 g, 5.7 
mmol) and acrylonitrile (0.40 mL, 6 mmol) after 
purification by column chromatography with an heptane-
ethyl acetate gradient as the eluent. 1H NMR (CDCl3): δ 7.13 (d, J = 16.5 Hz, 1H), 6.13 (s, 1H), 5.75 (d, J = 16.5 
Hz, 1H), 2.50-2.42 (m, 4H), 2.11 (m, 2H) ppm. 
 
(c) (E)-methyl 3-(3-oxocyclopent-1-enyl)prop-2-enoate 
(7). Diene 7 has been prepared by Heck reaction between 3-
iodocyclopent-3-enone[12] and methyl acrylate. A mixture 
of 3-iodocyclopent-3-enone (0.50 g, 2.4 mmol), methyl 
acrylate (0.54 mL, 6 mmol), Pd(OAc)2 (27 mg, 0.12 mmol), 
bis(diphenylphosphino)propane (25 mg, 0.06 mmol), Et3N (0.65 mL, 4.8 mmol) in DMF (10 mL) have been heated at 
85°C for 16h. After aqueous workup with HCl 0.5N, the 
organic layer was washed with NaHCO3 and water and 
evaporated to dryness. The final product 7 was purified by 
column chromatography on silica gel with an heptane/ethyl 
acetate gradient (Rf = 0.3 in heptane/ethyl acetate 1:1). 
Yield:  0.20 g, 50%.  1H NMR (CDCl3): δ 7.63 (d, J = 15.9 
Hz, 1H), 6.30 (d, J = 15.9 Hz, 1H), 6.29 (s, 1H), 3.78 (s, 
3H), 2.7 (m, 2H), 2.49 (m, 2H);13C NMR (CDCl3): δ 208.8 (CO), 168.3 (CO2Me), 166.2 (C), 138.6 (CH), 136.1 (CH), 
125.0 (CH), 52.3 (OMe), 35.1 (CH2), 27.0 (CH2) ppm. 
 
 
Phosphine promoted cyclization reactions. General 
Procedure: PBu3 (25-75 µmol) was added to a mixture of 
diene (0.25 mmol) and imine (0.50 mmol) in methyl ethyl 
ketone (or t-BuOH) (1mL) under argon. The mixture was 
heated overnight (18h) at the given temperature (see 
Schemes 3, 4 and Table 1). Conversion rates were 
determined on the crude mixture by 1H NMR, with 1,3,5-
trimethoxybenzene as the internal standard. After 
evaporation of the solvent, the final product was purified by 
column chromatography on silica gel.  
 
Methyl 2-(3-phenyl-4-oxo-2-tosyl-2,3,4,5,6,7-hexahydro-
1H-isoindol-1-yl)acetate (3a). Compound 3a was obtained 
in 90% yield (98 mg) after purification with an 
heptane/ethyl acetate gradient (Rf = 0.3 in heptane/ethyl 
acetate 1:1 ). 1H NMR (CDCl3): δ 7.66 (d, J = 8.2 Hz, 2H), 
7.3-7.2 (7H), 5.61 (d, J = 1.2 Hz, 1H, N-CHPh), 5.03 (br, m, 
NCH), 3.74 (s, 3H, OMe), 3.17 (dd, J = 15.9 and 4.0 Hz, 
1H, CH2CO2Me), 2.93 (d, J = 15.9 and 7.9 Hz, 1H, 
CH2CO2Me), 2.42 (s, Me), 2.4-2.2 (m, 4H), 2.0-1.9 (m, 
2H); 13C NMR (CDCl3): δ 194.4 (CO), 170.7 (CO2Me), 
158.5 (C=C-CO), 144.0 (C), 139.9 (C), 135.0 (C), 134.4 
(C), 129.8, 127.8, 127.7, 127.6, 68.2 (NCHPh), 65.6 (NCH), 
52.1 (OMe), 40.1 (CH2CO2Me), 37.7 (CH2CO), 23.6, 22.9, 
21.5 (Me) ppm. HRMS (ESI) calcd. for C24H25NO5S [M+Na]+: 462.1351, found: 462.1360. IR (neat) ν  1732, 
1673 cm-1. 
 
Methyl 2-(3-(4-chlorophenyl)-4-oxo-2-tosyl-2,3,4,5,6,7-
hexahydro-1H-isoindol-1-yl)acetate (3b). Compound 3b 
was obtained in 93% yield (110 mg) after purification with 
an heptane/ethyl acetate gradient (Rf = 0.3 in 
cyclohexane/ethyl acetate 1:1). 1H NMR (CDCl3): δ 7.65 (d, 
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J = 8.0 Hz, 2H), 7.3-7.2 (6H), 5.55 (d, J = 1.2 Hz, 1H, N-
CHAr), 5.0 (br, m, NCH), 3.74 (s, 3H, OMe), 3.16 (dd, J = 
16.0 and 4.0 Hz, 1H, CH2CO2Me), 2.95 (d, J = 15.9 and 8.0 
Hz, 1H, CH2CO2Me), 2.43 (s, Me), 2.4-2.2 (m, 4H), 2.0-1.9 (m, 2H); 13C NMR (CDCl3): δ 194.3 (CO), 170.6 (CO2Me), 
158.8 (C=C-CO), 144.2 (C), 138.5 (C), 134.7 (C), 134.1 
(C), 134.2 (C), 133.6 (C), 129.8, 129.0, 128.3, 127.8, 67.5 
(NCHAr), 65.5 (NCH), 52.1 (OMe), 39.9 (CH2CO2Me), 
37.7 (CH2CO), 23.6, 22.9, 21.5 (Me) ppm. HRMS (ESI) 
calcd. for C24H24ClNO5S [M+Na]+: 496.0961, found: 
496.0950. IR (neat)  ν 1732, 1675 cm-1. 
 
Methyl 2-(4-oxo-2-tosyl-3-(4-(trifluoromethyl)phenyl)-
2,3,4,5,6,7-hexahydro-1H-isoindol-1-yl)acetate (3c) was 
obtained in 78% yield after purification with an 
heptane/ethyl acetate gradient (Rf = 0.3 in 
cyclohexane/ethyl acetate 1:1). 1H NMR (CDCl3): δ 7.55 (d, 
J = 8.2 Hz, 2H), 7.41 (d, J = 8.5 Hz, 2H), 7.34 (d, J = 8.5 
Hz, 2H), 7.20 (d, J = 8.2 Hz, 2H), 5.58 (br, m, 1H, N-
CHAr), 5.0 (br, m, 1H NCH), 3.70 (s, 3H, OMe), 3.13 (dd, 
J = 16.0 and 4.1 Hz, 1H, CH2CO2Me), 2.97 (dd, J = 16.0 
and 7.4 Hz, 1H, CH2CO2Me), 2.36 (s, 3H, Me), 2.3-2.2 (m, 
4H), 2.0-1.9 (m, 2H); 13C NMR (CDCl3): δ 194.4 (CO), 
170.7 (CO2Me), 159.2 (C=C-CO), 144.5 (C), 143.9 (C), 
134.6 (C), 134.2 (C), 130.0 (C), 128.2, 128.0, 125.3, 125.2, 
67.9 (NCHAr), 65.8 (NCH), 52.2 (OMe), 40.0 
(CH2CO2Me), 37.8 (CH2CO), 23.8, 23.0, 21.6 (Me) ppm. 19F NMR (CDCl3): δ -62 ppm. HRMS (ESI) calcd. for 
C25H24F3NO5S [M+Na]+: 530.1225, found: 530.1221. IR (neat) ν 1733, 1674 cm-1. 
O
N
CO2Me
Ts
CF3
 
Methyl 2-(4-oxo-3-(thiophen-2-yl)-2-tosyl-2,3,4,5,6,7-
hexahydro-1H-isoindol-1-yl)acetate (3d) was obtained in 
76% yield ( 85 mg) after purification with an heptane/ethyl 
acetate gradient (Rf = 0.3 in cyclohexane/ethyl acetate 1:1). 1H NMR (CDCl3): δ 7.60 (d, J = 8.3 Hz, 2H), 7.19 (d, J = 
8.3 Hz, 2H), 7.08 (dd, J = 5.2 and 1.2 Hz, 1H), 6.99 (dd, J = 
3.5 and 1.2 Hz, 1H), 6.81 (dd, J = 5.2 and 3.5 Hz, 1H),  
5.88 (br, m, 1H, N-CHAr), 4.91 (br, m, 1H NCH), 3.63 (s, 
3H, OMe), 3.01 (dd, J = 16.0 and 4.2 Hz, 1H, CH2CO2Me), 
2.80 (dd, J = 16.0 and 8.0 Hz, 1H, CH2CO2Me), 2.33 (s, 3H 
Me), 2.3-2.2 (m, 4H), 2.0-1.8 (m, 2H); 13C NMR (CDCl3): δ 194.4 (CO), 170.7 (CO2Me), 159.0 (C=C-CO), 144.4 (C), 
144.2 (C), 135.0 (C), 134.7 (C), 130.0 (C), 127.8, 127.0, 
126.6, 125.2, 65.5 (NCHAr), 63.5 (NCH), 52.2 (OMe), 40.4 
(CH2CO2Me), 37.8 (CH2CO), 23.9, 23.1, 21.7 (Me) ppm. 
HRMS (ESI) calcd. for C22H23NO5S2 [M+Na]+: 468.0916, 
found: 468.0918. IR (neat)  ν 1734, 1676 cm-1. 
 
Methyl 2-(3-(4-methoxyphenyl)-4-oxo-2-tosyl-2,3,4,5,6,7 
-hexahydro-1H-isoindol-1-yl)acetate (3e). was obtained in 
82% yield (96 mg) after purification with an 
heptane/diethyl ether gradient (Rf = 0.3 in 
cyclohexane/ethyl acetate 1:1). 1H NMR (CDCl3): δ 7.62 (d, 
J = 8.3 Hz, 2H), 7.2-7.1 (m, 4H), 6.77 (d, J = 8.3 Hz, 2H), 
5.54 (br, m, 1H, N-CHAr), 4.95 (br, m, 1H NCH), 3.74 (s, 
3H, OMe- Ar), 3.68 (s, 3H, OMe), 3.09 (dd, J = 15.9 and 
4.0 Hz, 1H, CH2CO2Me), 2.82 (dd, J = 15.9 and 7.8 Hz, 1H, 
CH2CO2Me), 2.37 (s, 3H Me), 2.3-2.2 (m, 4H), 2.0-1.9 (m, 
2H); 13C NMR (CDCl3): δ 194.5 (CO), 170.8 (CO2Me), 
159.3 (C=C-CO), 158.3 (C), 144.0 (C), 135.2 (C), 134.6 
(C), 132.3 (C), 129.9, 128.8, 127.9, 113.7, 67.8 (NCHAr), 
65.5 (NCH), 55.3 (OMe-Ar), 52.1 (OMe), 40.2 
(CH2CO2Me), 37.8 (CH2CO), 23.8, 23.0, 21.6 (Me) ppm. 
HRMS (ESI) calcd. for C25H28NO6S [M+Na]+: 470.1637, 
found: 470.1619. IR (neat) ν 1732, 1673 cm-1. 
 
Methyl 2-(3-(naphthalen-1-yl)-4-oxo-2-tosyl-2,3,4,5,6,7-
hexahydro-1H-isoindol-1-yl)acetate (3f) was obtained in 
83% yield (101 mg) after purification with an heptane/ethyl 
acetate gradient (Rf = 0.3 in cyclohexane/ethyl acetate 1:1). 1H NMR (CDCl3): δ 8.22 (d, J = 8.6 Hz, 1H), 7.66 (d, J = 
8.6 Hz, 1H), 7.57 (d, J = 7.5 Hz, 1H), 7.46 (ddd, J = 8.6, 
6.9 and 1.6 Hz, 1H), 7.4-7.3 (m, 3H), 7.2-7.1 (m, 2H), 6.85 
(d, J = 8.6 Hz, 2H), 6.36 (br, m, 1H, N-CHAr), 5.20 (br, m, 
1H NCH), 3.71 (s, 3H, OMe), 3.23 (dd, J = 15.9 and 3.8 Hz, 
1H, CH2CO2Me), 3.06 (dd, J = 15.9 and 7.9 Hz, 1H, 
CH2CO2Me), 2.4-2.2 (m, 4H), 2.15 (s, 3H Me), 2.0-1.9 (m, 
2H); 13C NMR (CDCl3): δ 194.2 (CO), 171.1 (CO2Me), 
157.5 (C=C-CO), 143.7 (C), 136.5 (C), 136.2 (C), 134.4 
(C), 133.6 (C), 131.4 (C), 129.2, 128.5, 128.3, 128.0, 126.0, 
125.6, 125.0, 123.4, 65.4 (NCHAr), 63.2 (NCH), 52.2 
(OMe), 40.1 (CH2CO2Me), 37.8 (CH2CO), 23.8, 23.1, 21.5 (Me) ppm. HRMS (ESI) calcd. for C28H27NO5S [M+Na]+: 
512.1508, found: 512.1500. IR (neat)  ν 1734, 1677 cm-1. 
O
N
CO2Me
Ts
 
Methyl 2-(3-(4-nitrophenyl)-4-oxo-2-tosyl-2,3,4,5,6,7-
hexahydro-1H-isoindol-1-yl)acetate (3g) was obtained in 
47% yield ( 57 mg) after purification with an heptane/ethyl 
acetate gradient (Rf = 0.3 in cyclohexane/ethyl acetate 1:1). 1H NMR (CDCl3): δ 8.04 (d, J = 8.8 Hz, 2H), 7.59 (d, J = 
7.6 Hz, 2H), 7.46 (d, J = 8.8 Hz, 2H), 7.21 (d, J = 7.6 Hz, 
2H), 5.59 (d, J = 2.4 Hz, 1H, N-CHAr), 4.96 (br, m, 1H 
NCH), 3.72 (s, 3H, OMe), 2.96 (dd, J = 16.1 and 3.9 Hz, 
1H, CH2CO2Me), 3.15 (dd, J = 16.1 and 7.3 Hz, 1H, 
CH2CO2Me), 2.38 (s, 3H Me), 2.3-2.2 (m, 4H), 2.0-1.9 (m, 
2H); 13C NMR (CDCl3): δ 194.3(CO), 170.7 (CO2Me), 
159.7 (C=C-CO), 147.3 (C), 144.8 (C), 134.3 (C), 133.8 
(C), 130.2 (C), 128.9,  128.1, 123.6, 67.7 (NCHAr), 65.9 
(NCH), 52.4 (OMe), 39.8 (CH2CO2Me), 37.7 (CH2CO), 
23.8, 22.9, 21.7 (Me) ppm. HRMS (ESI) calcd. for 
C24H24N2O7S [M+Na]+: 507.1202, found: 507.1187. IR (neat)  ν 1733, 1676 cm-1. 
 
Methyl 2-(3-isopropyl-4-oxo-2-tosyl-2,3,4,5,6,7-
hexahydro-1H-isoindol-1-yl)acetate (3h) was obtained in 
71% yield ( 72 mg) after purification with an heptane/ethyl 
acetate gradient (Rf = 0.3 in cyclohexane/ethyl acetate 1:1). 1H NMR (CDCl3): δ 7.67 (d, J = 8.3 Hz, 2H), 7.26 (d, J = 
8.3 Hz, 2H), 4.76 (ddd, J = 8.9, 4.0 and 1.2 Hz, 1H, NCH), 
4.57 (d, J = 2.2 Hz, 1H, N-CHAr), 3.72 (s, 3H, OMe), 3.04 
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(dd, J = 16.3 and 4.2 Hz, 1H, CH2CO2Me), 2.66 (dd, J = 
16.3 and 8.8 Hz, 1H, CH2CO2Me), 2.38 (s, 3H Me), 2.3-2.2 (m, 1H), 2.1-2.2 (m, 1H), 1.9-1.8 (m, 1H), 0.97 (d, J = 7.0 
Hz, 3H, Me) 0.97 (d, J = 7.0 Hz, 3H, Me); 13C NMR 
(CDCl3): δ 195.2 (CO), 171.2 (CO2Me), 159.2 (C=C-CO), 
144.1 (C), 135.2 (C), 133.8 (C),130.0, 128.0, 71.1 (NCHAr), 
65.9 (NCH), 52.3 (OMe), 40.6 (CH2CO2Me), 37.9 (CH2CO), 32.8, 23.1, 21.7, 19.7, 18.8 (Me) ppm. HRMS (ESI) calcd. for C21H27NO5S [M+Na]+: 428.1508, found: 
428.1501. IR (neat)  ν 1735, 1672 cm-1. 
 
Methyl 2-(2-(4-chlorophenylsulfonyl)-4-oxo-3-phenyl-
2,3,4,5,6,7-hexahydro-1H-isoindol-1-yl)acetate (3i) was 
obtained in 82% yield (94 mg) after purification with an 
heptane/ethyl acetate gradient (Rf = 0.3 in 
cyclohexane/ethyl acetate 1:1). 1H NMR (CDCl3): δ 7.50 (d, 
J = 8.5 Hz, 2H), 7.25 (d, J = 8.5 Hz, 2H), 7.5-7.1 (m, 5H), 
5.51 (d, J = 2.1 Hz, 1H, N-CHAr), 4.93 (br, m, 1H NCH), 
3.58 (s, 3H, OMe), 2.98 (dd, J = 15.9 and 4.0 Hz, 1H, 
CH2CO2Me), 2.81 (dd, J = 15.9 and 7.5 Hz, 1H, 
CH2CO2Me), 2.2-2.1 (m, 4H), 1.9-1.7 (m, 2H); 13C NMR (CDCl3): δ 194.3 (CO), 170.6 (CO2Me), 158.2 (C=C-CO), 
139.5 (C), 139.4, 136.5 (C), 135.1 (C), 129.4, 129.2, 128.4, 
128.1, 127.8, 127.2, 68.5 (NCHAr), 65.7 (NCH), 52.2 
(OMe), 40.0 (CH2CO2Me), 37.8 (CH2CO), 23.7, 23.0 ppm. 
HRMS (ESI) calcd. for C23H22ClNO5S [M+Na]+: 482.0805, 
found: 482.0794. IR (neat) ν 1732, 1674 cm-1. 
 
Methyl 2-(2-(4-nitrophenylsulfonyl)-4-oxo-3-phenyl-
2,3,4,5,6,7-hexahydro-1H-isoindol-1-yl)acetate (3j) was 
obtained in 44% yield (52 mg) after purification with an 
heptane/ethyl acetate gradient (Rf = 0.3 in 
cyclohexane/ethyl acetate 1:1). 1H NMR (CDCl3): δ 8.15 (d, 
J = 8.8 Hz, 2H), 7.76 (d, J = 8.8 Hz, 2H), 7.19 (br, m, 5H), 
5.69 (d, J = 2.4 Hz, 1H, N-CHPh), 5.13 (br, m, 1H NCH), 
3.66 (s, 3H, OMe), 3.06 (dd, J = 15.8 and 4.4 Hz, 1H, 
CH2CO2Me), 2.94 (dd, J = 15.8 and 7.1 Hz, 1H, 
CH2CO2Me), 2.5-2.2 (m, 4H), 2.1-2.0 (m, 2H); 13C NMR (CDCl3): δ 194.1 (CO), 170.4 (CO2Me), 157.7 (C=C-CO), 
150.2 (C), 144.4 (C), 139.0 (C), 135.0 (C), 129.0, 128.6, 
128.5, 127.9, 124.2, 68.8 (NCHAr), 65.9 (NCH), 52.4 
(OMe), 39.6 (CH2CO2Me), 37.9 (CH2CO), 23.8, 23.1 ppm. 
HRMS (ESI) calcd. for C23H22N2O7S [M+Na]+: 493.1045, 
found: 493.1064. IR (neat) ν 1732, 1675 cm-1. 
 
1-(2-Oxopropyl)-3-phenyl-2-tosyl-2,3,6,7-hexahydro-1H-
isoindol-4(5H)-one (6a) was obtained in 91% yield (96 
mg) after purification with an heptane/ethyl acetate gradient 
(Rf = 0.3 in cyclohexane/ethyl acetate 1:1). 1H NMR (CDCl3): δ 7.61 (d, J = 8.3 Hz, 2H), 7.29-7.16 (m, 7H), 
5.61 (d, J = 1.2, 1H, N-CHAr), 5.03 (ddd, J = 7.9, 4.0 and 
1.2 Hz, 1H, NCH), 3.22 (dd, J = 17.4 and 3.3 Hz, 1H, 
CH2COMe), 2.93 (dd, J = 17.4 and 7.9 Hz, 1H, CH2COMe), 
2.34 (s, 3H, Me), 2.2-2.0 (m, 4H), 2.13 (s, 3H, COMe), 1.9-
1.7 (m, 2H); 13C NMR (CDCl3): δ 205.7 (COMe), 194.3 (CO), 159.2 (C=C-CO), 144.1 (C), 140.3 (C), 134.8 (C), 
134.0 (C), 130.0 (C), 128.3, 127.9, 129.8, 127.7, 68.1 
(NCHAr), 64.4 (NCH), 49.2 (CH2COMe), 37.7 (CH2CO),  
30.9 (COMe) 23.7, 22.9, 21.6 (Me) ppm. HRMS (ESI) 
calcd. for C24H25NO4S [M+Na]+: 446.1402, found: 
446.1416. IR (neat) ν 1711, 1671 cm-1. 
 
1-(2-Oxo-2-phenylethyl)-3-phenyl-2-tosyl-2,3,6,7-
hexahydro-1H-isoindol-4(5H)-one (6b) was obtained in 
47% yield ( 57 mg) after purification with an heptane/ethyl 
acetate gradient (Rf = 0.3 in cyclohexane/ethyl acetate 1:1). 1H NMR (CDCl3): δ 7.9−7.8 (m, 1H), 7.7-7.6 (m, 1H), 7.6-
7.5 (m, 2H), 7.5-7.4 (m, 1H), 7.4-7.3 (m, 2H), 7.3-7.1 (m, 
7H), 5.47 (d, J = 1.7, 1H, N-CHAr), 5.17 (ddd, J = 8.9, 3.0 
and 1.7 Hz, 1H, NCH), 3.76 (dd, J = 17.4 and 3.1 Hz, 1H, 
CH2CO2Ar), 3.44 (dd, J = 17.4 and 8.9 Hz, 1H, CH2CO2Ar), 
2.29 (s, 3H, Me), 2.2-2.1 (m, 4H), 2.0-1.8 (m, 2H); 13C 
NMR (CDCl3): δ 197.4 (COAr), 194.6 (CO), 159.8 (C=C-
CO), 144.2 (C), 140.4 (C), 134.0 (C), 130.1 (C), 130.0 (C), 
129.0, 128.5, 128.0, 127.7, 126.6, 68.2 (NCHAr), 65.2 
(NCH), 45.3 (CH2COAr), 37.9 (CH2CO), 24.2, 23.1, 21.7 (Me) ppm. HRMS (ESI) calcd. for C29H27NO4S [M+Na]+: 
508.1559, found: 508.1582. IR (neat) ν 1671cm-1
. 
 
N,N-Dimethyl-2-(4-oxo-3-phenyl-2-tosyl-2,3,4,5,6,7-
hexahydro-1H-isoindol-1-yl)acetamide (6c) was obtained 
in 68% yield ( 77 mg) after purification with an 
heptane/ethyl acetate gradient (Rf = 0.3 in 
cyclohexane/ethyl acetate 1:1). 1H NMR (CDCl3): δ 7.68 (d, 
J = 8.3Hz, 2H), 7.33 (d, J = 8.0Hz, 1H), 7.3-7.1 (m, 5H), 
6.86 (d, J = 8.0Hz, 1H), 5.44 (br, m, 1H, N-CHAr), 4.90 (br, 
m, 1H, NCH), 3.0-2.9 (m, 2H, CH2CONMe2), 2.90 (s, 3H, 
NMe2), 2.84 (s, 3H, NMe2), 2.35 (s, 3H, Me), 2.2-1.8 (m, 
6H); 13C NMR (CDCl3): δ 194.7 (CO), 169.5 (CH2CONMe2), 160.7 (C=C-CO), 144.3 (C), 140.4 (C), 
134.4 (C), 133.7 (C), 130.1 (C), 128.3, 128.0, 127.9, 68.1 
(NCHAr), 66.9 (NCH), 39.1 (CH2CONMe2), 37.8 (NMe2), 
35.7 (NMe2), 24.3, 23.1, 21.7 (Me) ppm. HRMS (ESI) 
calcd. for C25H28N2O4S [M+Na]+: 475.1668, found: 
475.1662. IR (neat) ν 1674, 1643 cm-1
.
 
 
2-(4-Oxo-3-phenyl-2-tosyl-2,3,4,5,6,7-hexahydro-1H-
isoindol-1-yl)acetonitrile (6d) was obtained in 32% yield 
(32 mg) after purification with an heptane/ethyl acetate 
gradient (Rf = 0.3 in cyclohexane/ethyl acetate 1:1). 1H 
NMR (CDCl3): δ 7.44 (d, J = 8.3Hz, 2H), 7.3-7.2 (m, 2H), 
7.1-7.0 (m, 5H), 5.46 (d, J = 2.3 Hz, 1H, N-CHAr), 4.73 (br, 
m, 1H, NCH), 3.0-2.9 (m, 2H, CH2CN), 2.26 (s, 3H, Me), 
2.2-2.1 (m, 4H), 2.0-1.9 (m, 2H); 13C NMR (CDCl3): δ 194.0 (CO), 154.9 (C=C-CO), 144.6 (C), 138.8 (C), 136.7 
(C), 134.3 (C), 130.0 (C), 128.4, 128.2, 128.1, 127.9, 116.7 
(CN), 68.7 (NCHAr), 64.6 (NCH), 37.9 (CH2CN), 23.9, 
23.1, 21.7 (Me) ppm. HRMS (ESI) calcd. for C23H22N2O3S [M+Na]+: 429.1249, found: 429.1258. IR (neat) ν 1676, 
2220 cm-1
.
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Diethyl (4-Oxo-3-phenyl-2-tosyl-2,3,4,5,6,7-hexahydro-
1H-isoindol-1-yl)methylphosphonate (6e) was obtained in 
41% yield (53 mg) after purification with an heptane/ethyl 
acetate gradient (Rf = 0.3 in cyclohexane/ethyl acetate 1:1). 1H NMR (CDCl3): δ 7.57 (d, J = 8.4Hz, 2H), 7.2-7.1 (m, 
7H), 5.44 (br, m, 1H, N-CHAr), 4.76 (br, m, 1H, NCH), 
4.1-3.9 (m, 4H, OCH2), 2.7-2.5 (m, 2H, CH2PO(OEt)2), 
2.29 (s, 3H, Me), 2.2-2.0 (m, 4H), 1.3-1.2 (m, 6H, 
OCH2CH3); 13C NMR (CDCl3): δ 194.7 (CO), 159.5 (C=C-
CO), 144.2 (C), 140.0 (C), 135.3 (C), 134.3 (C), 130.1 (C), 
128.4, 128.0, 127.9, 127.7, 68.0 (NCHAr), 64.3 (NCH), 
62.3 (d, J = 6.6 Hz, OCH2), 62.0 (d, J = 6.6 Hz, OCH2), 
37.8, 34.2, 32.4 (CH2PO(OEt)2), 29.8, 24.1, 23.2, 16.4 (d, J 
= 6.0 Hz, Me), 16.3 (d, J = 6.0 Hz, Me), ppm. 31P NMR 
(CDCl3): 25.5. HRMS (ESI) calcd. for C26H32NO6PS [M+Na]+: 540.1586, found: 540.1597. IR (neat) ν 1676 cm-
1
. 
 
 
N-Deprotection procedure: Synthesis of methyl 
(1S*,3R*)-4-oxo-3-phenyl-2,3,4,5,6,7-hexahydro-1H-
isoindol-1-yl)-acetate (3j’). To a solution of methyl 
{(1S*,3R*)-2-[(4-nitrophenyl)sulfonyl]-4-oxo-3-phenyl-
2,3,4,5,6,7-hexahydro-1H-isoindol-1-yl}acetate 3j (30 mg, 
0.06 mmol) and K2CO3 (35 mg, 0.25 mmol, 4.0 equiv.) in 
CH3CN-DMSO (95:5) (1 mL) at room temperature was 
added PhSH (23 µL, 0.22 mmol). The reaction mixture was 
heated at 40 °C for 2 h. The crude mixture was diluted with 
AcOEt (10 mL) and HCl 1N (10 mL) and the layers were 
separated. The aqueous layer was basified with solid K2CO3 (pH 10-11) and extracted with AcOEt (3x10 mL). The 
combined organic extracts were dried over MgSO4, filtered, 
and concentrated in vacuo to provide 3j’ (12 mg, 66%). 
1H NMR (CDCl3): δ 7.34 (d, J = 7.1 Hz, 2H), 7.30 (dd, J = 
7.1 and 6.9 Hz, 2H),7.22 (t, J = 6.9 Hz, 1H), 5.25 (s, 1H, N-
CHPh), 4.59 (dd, J = 4.4 and 4.1 Hz, 1H, NCH), 3.71 (s, 3H, 
OMe), 2.79 (dd, J = 15.6 and 4.1 Hz, 1H, CH2CO2Me), 
2.60 (dd, J = 15.6 and 4.4 Hz, 1H, CH2CO2Me), 2.51-2.30 (m, 4H), 2.22 (br, s, NH), 1.55-1.26 (m, 2H). 13C NMR 
(CDCl3): δ 195.6 (CO), 171.8 (CO2Me), 162.3 (C=C-CO), 
143.6 (C), 138.2 (C), 128.2, 127.5, 127.2, 65.7 (NCHPh), 
63.1 (NCH), 51.9 (OMe), 41.0 (CH2CO2Me), 38.2 (CH2CO), 23.8, 23.5 ppm. HRMS (ESI) calcd. for 
C17H19NO3 [M+H]+: 286.1443, found: 286.1449. IR (neat) 
ν  1733, 1669 cm-1.  
 
 
Computational methods. Geometry optimization was 
carried out at the B97-D level of theory[17] with the def2-
TZVPP basis set.[18] These calculations were accelerated 
using the Multipole Accelerated Resolution of Identity for J 
(MARI-J) approximation method,[19] as implemented in 
Turbomole 6.2.[20] LUMO have been drawn using the 
gOpenMol 3.00 package.[21] The molecular orbital 
coefficients have been computed at the HF/STO-3G level, 
based on the DFT gas-phase geometries.[16c] Hückel 
calculations were carrried out with the Hückel simple 
program.[22] 
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